Jodi Devlin is Chief of Clinical Operations of MedTech Acquisition Corp. Currently has a direct ownership of 52,764 shares of MTACW, which is worth approximately $11,608. The most recent transaction as insider was on May 19, 2025, when has been sold 4,764 shares (Common Stock) at a price of $5.18 per share, resulting in proceeds of $24,677. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.8K
57.99% 3M change
201.51% 12M change
Total Value Held $11,608

Jodi Devlin Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2025
SELL
Open market or private sale
$24,677 $5.18 p/Share
4,764 Reduced 8.28%
52,764 Common Stock
May 19 2025
BUY
Grant, award, or other acquisition
$124,998 $5.18 p/Share
24,131 Added 29.55%
57,528 Common Stock
Feb 18 2025
BUY
Grant, award, or other acquisition
-
5,272 Added 13.63%
33,397 Common Stock
Jan 27 2025
BUY
Grant, award, or other acquisition
-
10,625 Added 27.42%
28,125 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
17,500 Added 50.0%
17,500 Common Stock
JD

Jodi Devlin

Chief of Clinical Operations
Westminster, CO

Track Institutional and Insider Activities on MTACW

Follow MedTech Acquisition Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTACW shares.

Notify only if

Insider Trading

Get notified when an Med Tech Acquisition Corp insider buys or sells MTACW shares.

Notify only if

News

Receive news related to MedTech Acquisition Corp

Track Activities on MTACW